Featured Posts
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Search Posts
C-SPAN
VIDEO: Senior Fellow Joel Zinberg Joins C-Span to Discuss the ACA and more
Senior Fellow Joel Zinberg joins C-Span to discuss the Affordable Care Act and the future of healthcare: Click here to read…
Blog
CEI Joins Coalition Urging FDA Not to Ban Synthetic Nicotine
This week CEI joined a coalition of groups urging Food and Drug Administration (FDA) Commissioner Robert Califf not to prohibit synthetic nicotine (read the…
New York Post
Mayor Adams Wants the Tots to Stay Masked Up, Instead of Listening to Science
Mayor Adams and his new health commissioner, Dr. Ashwin Vasan, have decided to extend the city’s school mask mandate for children under 5. This…
Letters
CEI Joins Coalition Letter on FDA Ban on Synthetic Nicotine
Dear Commissioner Califf, We write to you in opposition to a new regulation signed into law by Congress that will effectively ban vapor…
News Release
House Votes to Decriminalize Marijuana – an Important First Step
The House on Friday passed legislation to decriminalize marijuana at the federal level. The Marijuana Opportunity Reinvestment and Expungement (or MORE)…
The Chicago Morning Answer
Radio: Joel Zinberg Joins Chicago’s Morning Answer to Discuss Vaccine Mandates
Senior Fellow Joel Zinberg joins the Dan Proft Show to discuss vaccine mandates and more. Click here to read more.